- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Next Generation ACO Model and Oncology Medical Home Model
During this segment, Michael Kolodziej, MD, and Ted Okon, MBA, discuss how programs such as CMS’ Next Generation ACO model and the Community Oncology Alliance’s (COA’s) Oncology Medical Home model are transforming oncology care.
Despite CMS’s effort to analyze the results of the implementation of the Pioneer ACO and Medicare Shared Savings Program models, and consequently implement changes into their new Next Generation ACO model, Dr Kolodziej and Mr Okon are not confident that all of the learnings from these programs have been incorporated.
Dr Kolodziej expects organizations on the private sector side to have more success in altering this type of care delivery model. Dr Kolodziej highlights the efforts of the COA specifically, and discusses their latest initiative, an enhanced version of their Oncology Medical Home model that includes a reformed reimbursement methodology.
Mr Okon further explains how the Oncology Medical Home model has developed, discusses how the Oncology Medical Home model differs from other innovative delivery models (eg, the CMS ACO models), and describes how new models can aid in the transformation of oncology care.
Watch our related Peer Exchange, Oncology Stakeholders Summit, Spring 2015
Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities
April 22nd 2025Researchers are calling for more targeted efforts to improve health equity after a new analysis revealed that cancer symptom documentation and burden vary across certain demographics.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More
